These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


212 related items for PubMed ID: 26377572

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Targeted newborn screening for sickle-cell anemia: Sickling test (Emmel test) boundaries in the prenatal assessment in West African area].
    Diallo DA, Guindo A, Touré BA, Sarro YS, Sima M, Tessougué O, Baraika MA, Guindo P, Traoré M, Diallo M, Dorie A.
    Rev Epidemiol Sante Publique; 2018 May; 66(3):181-185. PubMed ID: 29625861
    [Abstract] [Full Text] [Related]

  • 24. Potential of point of care tests for newborn screening for sickle cell disease: Evaluation of HemotypeSC™ and sickle SCAN® in Tanzania.
    Christopher H, Josephat E, Kaywanga F, Saul S, Mshana I, Kunambi P, Nasser A, Chamba C, Makani J, Nkya S.
    Int J Lab Hematol; 2022 Oct; 44(5):959-965. PubMed ID: 35775883
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Saving lives through early diagnosis: the promise and role of point of care testing for sickle cell disease.
    Dexter D, McGann PT.
    Br J Haematol; 2022 Jan; 196(1):63-69. PubMed ID: 34340260
    [Abstract] [Full Text] [Related]

  • 29. Optical absorbance-based rapid test for the detection of sickle cell trait and sickle cell disease at the point-of-care.
    Srinivasan R, Eugene Christo VR, Nambannor Kunnath R, Katare P, Venukumar A, Nambison NKM, Gorthi SS.
    Spectrochim Acta A Mol Biomol Spectrosc; 2022 Oct 15; 279():121394. PubMed ID: 35660146
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Using dried blood spot on HemoTypeSC™, a new frontier for newborn screening for sickle cell disease in Nigeria.
    Okeke CO, Chianumba RI, Isa H, Asala S, Nnodu OE.
    Front Genet; 2022 Oct 15; 13():1013858. PubMed ID: 36386848
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. High birth prevalence of sickle cell disease in Northwestern Tanzania.
    Ambrose EE, Makani J, Chami N, Masoza T, Kabyemera R, Peck RN, Kamugisha E, Manjurano A, Kayange N, Smart LR.
    Pediatr Blood Cancer; 2018 Jan 15; 65(1):. PubMed ID: 28766840
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Abnormality of erythrocyte membrane n-3 long chain polyunsaturated fatty acids in sickle cell haemoglobin C (HbSC) disease is not as remarkable as in sickle cell anaemia (HbSS).
    Ren H, Ghebremeskel K, Okpala I, Ugochukwu CC, Crawford M, Ibegbulam O.
    Prostaglandins Leukot Essent Fatty Acids; 2006 Jan 15; 74(1):1-6. PubMed ID: 16314081
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.